XML 37 R27.htm IDEA: XBRL DOCUMENT
v3.22.1

Detail of Certain Accounts | 3 Months Ended
--- | ---
Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
Detail of Certain Accounts | DETAIL OF CERTAIN ACCOUNTS: Cash and Cash Equivalents Amounts related to Quanta’s cash and cash equivalents based on geographic location of the bank accounts were as follows (in thousands):
|  | March 31, 2022 |  | December 31, 2021
Cash and cash equivalents held in domestic bank accounts |  | $ | 211,128 |  |  | $ | 205,781 |
Cash and cash equivalents held in foreign bank accounts |  | 27,130 |  |  | 23,316 |
Total cash and cash equivalents |  | $ | 238,258 |  |  | $ | 229,097 |
Quanta considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents, which are carried at fair value. As of March 31, 2022 and December 31, 2021, cash equivalents were $141.4 million and $140.0 million and consisted primarily of money market investments and money market mutual funds and are discussed further in Note 17. Cash and cash equivalents held by joint ventures, which are either consolidated or proportionately consolidated, are available to support joint venture operations, but Quanta cannot utilize those assets to support its other operations. Quanta generally has no right to cash and cash equivalents held by a joint venture other than participating in distributions, to the extent made, and in the event of dissolution. Cash and cash equivalents held by Quanta’s wholly-owned captive insurance company are generally not available for use in support of its other operations. Amounts related to cash and cash equivalents held by joint ventures and the captive insurance company, which are included in Quanta’s total cash and cash equivalents balances, were as follows (in thousands):
|  | March 31, 2022 |  | December 31, 2021
Cash and cash equivalents held by domestic joint ventures |  | $ | 17,309 |  |  | $ | 21,828 |
Cash and cash equivalents held by foreign joint ventures |  | 5,914 |  |  | 3,461 |
Total cash and cash equivalents held by joint ventures |  | 23,223 |  |  | 25,289 |
Cash and cash equivalents held by captive insurance company |  | 134,758 |  |  | 133,302 |
Cash and cash equivalents not held by joint ventures or captive insurance company |  | 80,277 |  |  | 70,506 |
Total cash and cash equivalents |  | $ | 238,258 |  |  | $ | 229,097 |
Accounts Payable and Accrued Expenses Accounts payable and accrued expenses consisted of the following (in thousands):
|  | March 31, 2022 |  | December 31, 2021
Accounts payable, trade |  | $ | 1,341,088 |  |  | $ | 1,251,118 |
Accrued compensation and related expenses |  | 442,264 |  |  | 547,161 |
Other accrued expenses |  | 535,037 |  |  | 456,392 |
Accounts payable and accrued expenses |  | $ | 2,318,389 |  |  | $ | 2,254,671 |

X
- Definition Detail of certain balance sheet accounts. + References No definition available. + Details
Name: | pwr_DetailOfCertainBalanceSheetAccountsTextBlock
Namespace Prefix: | pwr_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration